Emergent use of anticoagulation for treatment of patients with ischemic stroke

Stroke

Volumn 33, Issue 3, 2002, Pages 856-861

  Adams Jr , Harold P ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Anticoagulants; Heparin; Recurrence; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; CERTOPARIN; DANAPAROID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; TINZAPARIN;

ANTICOAGULATION; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG SAFETY; HUMAN; LUNG EMBOLISM; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANTICOAGULANTS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; DISEASE PROGRESSION; EMERGENCY TREATMENT; HUMANS; RECURRENCE;

EID: 0036199156     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/hs0302.104628     Document Type: Review

References (36)

1. Treatment of ischaemic stroke
2. Is there still a role for intravenous heparin in acute stroke? Yes
3. Intravenous unfractionated heparin in patients with acute ischemic stroke: A treatment to be used in the context of randomized trials only
4. Immediate anticoagulation in acute focal brain ischemia revisited: Gathering the evidence
5. Antithrombotic and thrombolytic therapy for ischemic stroke
6. Heparin and oral anticoagulants in the treatment of brain ischemia
7. Intravenous heparin for acute stroke: What can we learn from the megatrials?
8. Heparin in acute ischemic stroke: The case for a new clinical trial
9. How Twin Cities neurologists treat ischemic stroke: Policies and trends
10. Use of antithrombotic drugs in the treatment of acute ischemic stroke: A survey of neurologists in practice in the United States
11. Guidelines for the management of patients with acute ischemic stroke: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
12. Low-molecular-weight heparin for the treatment of acute ischemic stroke
13. Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin
14. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke
15. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial
16. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: A double-blind randomised study
17. Tinzaparin in acute ischaemic stroke (TAIST): A randomised aspirin-controlled trial
18. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke
19. Hemorrhagic transformation within 36 hours of a cerebral infarct: Relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS 1) cohort
20. Tissue plasminogen activator for acute ischemic stroke
21. CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
22. Hemorrhagic transformation in acute ischemic stroke
23. Early anticoagulation after large cerebral embolic infarction: A safety study
24. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: A meta-analysis of randomized controlled trials
25. Anticoagulation in acute ischaemic stroke: Deep vein thrombosis prevention and long-term outcomes
26. Treatment of acute ischemic stroke
27. Prophylaxis of venous thromboembolism in stroke patients
28. AHA Scientific Statement: Supplement to the guidelines for the management of transient ischemic attacks: A statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association
29. Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project
30. Effectiveness of heparin treatment for progressing ischaemic stroke: Before and after study
31. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke: A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association
32. Canadian guidelines for intravenous thrombolytic treatment in acute stroke: A consensus statement of the Canadian Stroke Consortium
33. Risk of immediate heparin after rt-PA therapy in acute ischemic stroke
34. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: Determination of etiological, topographic, and radiological outcome factors
35. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators Prolyse in Acute Cerebral Thromboembolism
36. PROACT II: Recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism: Initial trial results